‘An increased ability to disease-free’: Moderna CEO & Merck’s Dr. Li on skin cancel vaccine trial
Stephane Bancel, Moderna CEO, and Dr. Dean Li, Merck Research Laboratories president, join ‘Squawk Box’ to discuss details of an experimental personalized cancer vaccine that showed positive initial results in its first-ever late-stage trial, how the mRNA-based shot in combination with Merck’s immunotherapy Keytruda could serve as a new treatment option for melanoma, and more.
